论著

脐带血干细胞移植治疗异染性脑白质营养不良3例报告

  • 管丽蔷 ,
  • 姜帆 ,
  • 陈姣 ,
  • 刘周阳 ,
  • 孙媛
展开
  • 北京京都儿童医院 血液科(北京 102208)

收稿日期: 2022-10-24

  网络出版日期: 2024-03-06

Umbilical cord blood transplantation in the treatment of metachromatic leukodystrophy: a report of 3 cases

  • Liqiang GUAN ,
  • Fan JIANG ,
  • Jiao CHEN ,
  • Zhouyang LIU ,
  • Yuan SUN
Expand
  • Department of Hematology, Beijing Jingdu children's Hospital, Beijing 102208, China

Received date: 2022-10-24

  Online published: 2024-03-06

摘要

目的 探讨脐带血造血干细胞移植(UCBT)治疗异染性脑白质营养不良(MLD)的安全性及有效性。方法 回顾性分析2019年4月至9月行非血缘UCBT治疗的3例MLD患儿的临床资料。结果 3例患儿均表现为走路障碍、进行性运动功能倒退,2例出现智力落后;3例均出现溶酶体芳基硫酸脂酶A(ARSA)下降,头部MRI均示脑白质不同程度的异常信号。3例均为ARSA基因复合杂合突变。3例均行非血缘UCBT,使用氟达拉滨+环磷酰胺+兔抗人胸腺细胞免疫球蛋白+白消安方案预处理,环孢素+吗替麦考酚酯+甲氨蝶呤预防移植物抗宿主病(GVHD)。3例均植入成功,移植后1个月内全血均达到完全供者嵌合状态,头部MRI均提示脑实质病变逐渐停止进展,ARSA均逐渐恢复正常。3例患儿均出现感染,2例出现急性移植物抗宿主反应(aGVHD),1例出现慢性移植物抗宿主反应(cGVHD),经抗感染及调节免疫治疗后均好转。末次随访时间为2022年8月,3例患儿均存活,其远期疗效及神经系统恢复情况仍需长期随访。结论 UCBT是阻止MLD进展的一种安全及有效治疗手段。

本文引用格式

管丽蔷 , 姜帆 , 陈姣 , 刘周阳 , 孙媛 . 脐带血干细胞移植治疗异染性脑白质营养不良3例报告[J]. 临床儿科杂志, 2024 , 42(3) : 249 -252 . DOI: 10.12372/jcp.2024.22e1424

Abstract

Objective To investigate the safety and efficacy of umbilical cord blood transplantation (UCBT) in the treatment of metachromatic leukodystrophy (MLD). Methods The clinical data of 3 MLD children treated with unrelated UCBT from April to September 2019 were retrospectively analyzed. Results All the 3 children showed walking disorder, progressive motor function regression, and 2 of them showed mental retardation. Lysosomal arylsulfatase A (ARSA) decreased in all of them. Head MRI of all the 3 children showed abnormal signals of different degrees in the white matter of the brain and they all had compound heterozygous mutations of ARSA gene. All the 3 children were treated with unrelated UCBT, and the pre-treatment regimen was fludarabine + cyclophosphamide + rabbit anti-human thymocyte immunoglobulin + busulfan, and the prevention of graft-versus-host disease (GVHD) was treated with cyclosporine + mycophenolate mofetil + methotrexate. All the 3 children were successfully implanted, and the whole blood of all children reached complete donor chimerism within 1 month after transplantation. Head MRI showed that the progression of brain parenchymal lesions gradually stopped, and ARSA levels gradually returned to normal. All 3 patients developed infection, 2 developed acute GVHD and 1 developed chronic GVHD. After anti-infection and regulatory immunotherapy, they all improved. The last follow-up was in August 2022, and all 3 patients survived. Long-term efficacy and neurological recovery still require long-term follow-up.Conclusion UCBT is a safe and effective treatment to prevent the progression of MLD.

参考文献

[1] 吴江, 贾建平. 神经病学[M]. 北京: 人民卫生出版社, 2015: 287-288.
[2] Borges FM, Costa MJGD, Carneiro ZA, et al. Metachromatic leukodystrophy: pediatric presentation and the challenges of early diagnosis[J]. Rev Assoc Med Bras (1992), 2020, 66(10): 1344-1350.
[3] de Hosson LD, van de Warrenburg BP, Preijers FW, et al. Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature[J]. Bone Marrow Transplant, 2011, 46(8): 1071-1076.
[4] Videb?k C, Stokholm J, Sengel?v H, et al. Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review[J]. JIMD Rep, 2021, 60 (1): 96-104.
[5] Wang W. Surgical treatment of a 36-year-old patient with asphyxiating thoracic dysplasia[J]. Interact Cardiovasc Thorac Surg, 2021, 34(1): 153-155.
[6] Al-Wassia RK, Al-Qathmi MS. Microcystic adnexal carcinoma of the scalp treated with surgical resection along with chemoradiation: a case report and review of the literature[J]. Saudi J Biol Sci, 2021, 28(12): 7117-7124.
[7] van den Broek BTA, Page K, Paviglianiti A, et al. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies[J]. Blood Adv, 2018, 2(1): 49-60.
[8] 孙珊珊, 赵翠萍. 异染性脑白质营养不良的研究进展[J]. 青岛大学学报 (医学版), 2021, 57(4): 621-625.
[9] Shaimardanova AA, Chulpanova DS, Solovyeva VV, et al. Metachromatic leukodystrophy, diagnosis,modeling,and treatment approaches[J]. Front Med (Lausanne), 2020, 7: 576221.
[10] 张巍, 姚生, 常杏芝, 等. 无脑白质影像学改变的晚发婴儿型异染性脑白质营养不良[J]. 中国现代神经疾病杂志, 2005, 5(6): 385-388.
[11] Wolf NI, Breur M, Plug B, et al. Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction[J]. Ann Clin Transl Neurol, 2020, 7(2): 169-180.
[12] Beerepoot S, Heijst H, Roos B, et al. Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy[J]. Brain, 2022, 145(1): 105-118.
[13] Giarraputo J, Giamberardino S, Arvai S, et al. Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis[J]. J Neuroimmunol, 2021, 354: 577541.
[14] Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia[J]. Blood, 2001, 97( 10) : 2962-2971.
[15] Barker JN, Davies SM, DeFor TE, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis[J]. Blood, 2001, 97(10): 2957-2961.
文章导航

/